Xvivo Perfusion AB


XVIVO is a leading MedTech company dedicated to extending the life of all major organs to enable more transplantations and save more lives. Founded in 1998, XVIVO develops innovative technologies and services for organ preservation, transport, and assessment, aiming to increase organ utilization, improve outcomes, and support clinicians and researchers worldwide. Their mission is to make more organs available for patients in need and to ensure nobody dies waiting for a new organ.

Industries

biotechnology
cosmetic-surgery
health-care
medical

Nr. of Employees

medium (51-250)


Patents

Isolated organ evaluation and treatment

US-12216114-B2

View Details

Methods of preparing pH-stabilized and heat-sterilized organ preservation and/or perfusion solutions

US-11849721-B2

View Details

Afterload device for a beating heart during examination thereof

US-10405756-B2

View Details

Medical fluid, a method of treatment and use of the fluid

US-10271540-B2

View Details

Priming solutions for cardiopulmonary bypass

US-8969323-B2

View Details

Products

EVLP platform with integrated monitoring and perfusate management

Comprehensive ex vivo lung perfusion system integrating in-line gas monitoring (pH/PO2), perfusate management pumps, ventilator interface, oxygenation and heat-exchange modules, user displays for trending and safety sensors.

Portable kidney hypothermic pulsatile perfusion device (transport configuration)

Portable system for hypothermic pulsatile perfusion of donor kidneys with oxygenated solution intended to extend preservation during transport.

Multi-protocol liver perfusion system

Device platform supporting hypothermic, dual hypothermic and normothermic liver perfusion protocols for preservation and assessment.

Dextran-based low-potassium extracellular preservation solution (ready-to-use)

Buffered extracellular low-potassium dextran-based preservation solution pre-supplemented with calcium and pH buffers for flushing, cold static storage and transport of lungs.


Services

Third-party organ recovery and transport coordination including surgical recovery teams and logistics to deliver donor organs to transplant clinics.

Practical and theoretical training sessions for transplant teams delivered at company facilities or at partner centers, including masterclasses, webinars and workshops, plus recorded on-demand content.

Webinars, masterclasses and recorded sessions covering best practices, clinical evidence and protocol guidance for machine perfusion.

Provision of instructions for use, product documentation, presentation materials and technical support resources for clinical and technical users.

Round-the-clock operational and clinical support for organ recovery coordination and urgent clinical inquiries.

Structured intake and reporting process for product complaints, including online forms to capture event dates, product identifiers and incident descriptions to support investigations and regulatory follow-up.

View All Services

Expertise Areas

  • Organ perfusion and machine perfusion systems
  • Ex vivo lung perfusion and lung viability assessment
  • Hypothermic oxygenated perfusion methods for abdominal organs
  • Perfusate formulation and preservation solution development
  • Show More (8)

Key Technologies

  • Machine perfusion (ex vivo perfusion) platforms
  • Hypothermic oxygenated perfusion methods
  • Normothermic ex vivo lung perfusion (EVLP)
  • Controlled oxygenated rewarming workflows
  • Show More (10)

News & Updates

Announcement of the first patient enrollment in the US PRESERVE CAP study for XVIVO Heart Assist Transport device.

The company released its interim report for the first half of 2025.

Recognition for life-saving innovation and growth in the U.S. market.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.